# Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery

> **NCT04063358** · PHASE3 · UNKNOWN · sponsor: **Second Military Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Diabetic Macular Edema
- Cataract

## Interventions

- **DRUG:** Lucentis

## Key facts

- **NCT ID:** NCT04063358
- **Lead sponsor:** Second Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-22
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04063358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04063358, "Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04063358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*